Autolus Therapeutics (AUTL) Misses Q3 EPS by 10c

Autolus Therapeutics (NASDAQ: AUTL) reported Q3 EPS of ($0.31), $0.10 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nutrien warns shareholders about below-market mini-tender offer
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00